Matches in Nanopublications for { ?s ?p "[Furthermore, in a cohort of patients with newly diagnosed RA, elevated PAR(2) expression in both CD14+ and CD3+ cells was significantly reduced 3 months after methotrexate or sulfasalazine treatment and this reduction correlated significantly with the reduction in the 28-joint Disease Activity Scale score (p<0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- assertion description "[Furthermore, in a cohort of patients with newly diagnosed RA, elevated PAR(2) expression in both CD14+ and CD3+ cells was significantly reduced 3 months after methotrexate or sulfasalazine treatment and this reduction correlated significantly with the reduction in the 28-joint Disease Activity Scale score (p<0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Furthermore, in a cohort of patients with newly diagnosed RA, elevated PAR(2) expression in both CD14+ and CD3+ cells was significantly reduced 3 months after methotrexate or sulfasalazine treatment and this reduction correlated significantly with the reduction in the 28-joint Disease Activity Scale score (p<0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP957630.RAZDrHqEKsGFm7WJlhZXxRnjX0QXz-ImhxSYihLoEVcco130_assertion description "[Furthermore, in a cohort of patients with newly diagnosed RA, elevated PAR(2) expression in both CD14+ and CD3+ cells was significantly reduced 3 months after methotrexate or sulfasalazine treatment and this reduction correlated significantly with the reduction in the 28-joint Disease Activity Scale score (p<0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP957630.RAZDrHqEKsGFm7WJlhZXxRnjX0QXz-ImhxSYihLoEVcco130_provenance.
- NP957632.RAbjjeiPfQUK_lcrww0QZbz4wEwNiDV6JUrA6-LgqMUaU130_assertion description "[Furthermore, in a cohort of patients with newly diagnosed RA, elevated PAR(2) expression in both CD14+ and CD3+ cells was significantly reduced 3 months after methotrexate or sulfasalazine treatment and this reduction correlated significantly with the reduction in the 28-joint Disease Activity Scale score (p<0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP957632.RAbjjeiPfQUK_lcrww0QZbz4wEwNiDV6JUrA6-LgqMUaU130_provenance.
- NP390409.RAh4lzcI5-ueaytgixOVOz2mY4xNIgbS_MRFUNE4kDh60130_assertion description "[Furthermore, in a cohort of patients with newly diagnosed RA, elevated PAR(2) expression in both CD14+ and CD3+ cells was significantly reduced 3 months after methotrexate or sulfasalazine treatment and this reduction correlated significantly with the reduction in the 28-joint Disease Activity Scale score (p<0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP390409.RAh4lzcI5-ueaytgixOVOz2mY4xNIgbS_MRFUNE4kDh60130_provenance.
- NP957623.RAssu0bCgvwJ3PPEezFQRlU6USbQwuIZUhoNG98ojJPK4130_assertion description "[Furthermore, in a cohort of patients with newly diagnosed RA, elevated PAR(2) expression in both CD14+ and CD3+ cells was significantly reduced 3 months after methotrexate or sulfasalazine treatment and this reduction correlated significantly with the reduction in the 28-joint Disease Activity Scale score (p<0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP957623.RAssu0bCgvwJ3PPEezFQRlU6USbQwuIZUhoNG98ojJPK4130_provenance.
- NP586113.RAOcV7KOPj5N2gaOi_bOI2FDbklXwp8KarBA40r2hM5X0130_assertion description "[Furthermore, in a cohort of patients with newly diagnosed RA, elevated PAR(2) expression in both CD14+ and CD3+ cells was significantly reduced 3 months after methotrexate or sulfasalazine treatment and this reduction correlated significantly with the reduction in the 28-joint Disease Activity Scale score (p<0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP586113.RAOcV7KOPj5N2gaOi_bOI2FDbklXwp8KarBA40r2hM5X0130_provenance.
- NP290056.RAPPbQeuT393g6taOPbIdPoGa5N_u2tAKtX1tvkCvq3JY130_assertion description "[Furthermore, in a cohort of patients with newly diagnosed RA, elevated PAR(2) expression in both CD14+ and CD3+ cells was significantly reduced 3 months after methotrexate or sulfasalazine treatment and this reduction correlated significantly with the reduction in the 28-joint Disease Activity Scale score (p<0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP290056.RAPPbQeuT393g6taOPbIdPoGa5N_u2tAKtX1tvkCvq3JY130_provenance.